Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 1.5x - 1.7x | 1.6x |
| Selected Fwd Ps Multiple | 1.4x - 1.6x | 1.5x |
| Fair Value | ﷼115.61 - ﷼127.77 | ﷼121.69 |
| Upside | -3.8% - 6.3% | 1.2% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Al-Dawaa Medical Services Company | 416,300.0% | SASE:4163 |
| Abdullah Al-Othaim Markets Company | 400,100.0% | SASE:4001 |
| Almunajem Foods Company | 416,200.0% | SASE:4162 |
| Abdulaziz and Mansour Ibrahim Albabtin Co. | 954,900.0% | SASE:9549 |
| BinDawood Holding Company | 416,100.0% | SASE:4161 |
| Nahdi Medical Company | 416,400.0% | SASE:4164 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4163 | 4001 | 4162 | 9549 | 4161 | 4164 | |||
| SASE:4163 | SASE:4001 | SASE:4162 | SASE:9549 | SASE:4161 | SASE:4164 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 10.2% | 5.6% | 6.7% | 24.0% | 3.2% | 3.8% | ||
| 3Y CAGR | 8.6% | 8.4% | 9.1% | 16.8% | 9.0% | 5.4% | ||
| Latest Twelve Months | 12.6% | 3.1% | 0.9% | 41.0% | 3.2% | 10.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 5.5% | 5.8% | 8.3% | 8.2% | 5.4% | 9.8% | ||
| Prior Fiscal Year | 5.7% | 4.7% | 8.5% | 4.0% | 4.9% | 10.2% | ||
| Latest Fiscal Year | 5.7% | 4.8% | 8.3% | 2.6% | 4.8% | 8.7% | ||
| Latest Twelve Months | 5.8% | 4.4% | 6.1% | 2.6% | 4.8% | 8.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 12.3x | 14.7x | 17.2x | 24.3x | 16.9x | 14.0x | ||
| Price / LTM Sales | 1.0x | 0.7x | 1.2x | 0.6x | 1.2x | 1.6x | ||
| LTM P/E Ratio | 17.1x | 15.4x | 19.6x | 23.0x | 25.6x | 18.8x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.6x | 1.0x | 1.2x | |||||
| Historical LTM P/S Ratio | 0.0x | 1.9x | 2.6x | |||||
| Selected Price / Sales Multiple | 1.5x | 1.6x | 1.7x | |||||
| (x) LTM Sales | 9,824 | 9,824 | 9,824 | |||||
| (=) Equity Value | 14,766 | 15,543 | 16,320 | |||||
| (/) Shares Outstanding | 130.0 | 130.0 | 130.0 | |||||
| Implied Value Range | 113.58 | 119.56 | 125.54 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 113.58 | 119.56 | 125.54 | 120.20 | ||||
| Upside / (Downside) | -5.5% | -0.5% | 4.4% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4163 | 4001 | 4162 | 9549 | 4161 | 4164 | |
| Value of Common Equity | 6,409 | 7,308 | 4,032 | 124 | 6,960 | 15,626 | |
| (/) Shares Outstanding | 85.0 | 900.0 | 60.0 | 3.4 | 1,141.0 | 130.0 | |
| Implied Stock Price | 75.40 | 8.12 | 67.20 | 36.50 | 6.10 | 120.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 75.40 | 8.12 | 67.20 | 36.50 | 6.10 | 120.20 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |